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Abstract
Background: Housekeeping genes are routinely used as endogenous references to account for
experimental differences in gene expression assays. However, recent reports show that they could
be de-regulated in different diseases, model animals, or even under varied experimental conditions,
which may lead to unreliable results and consequently misinterpretations. This study focused on
the selection of suitable reference genes for quantitative PCR in human hepatitis B virus (HBV)-
related hepatocellular carcinoma (HCC) with different clinical outcomes.
Methods: We evaluated 6 commonly used housekeeping genes' expression levels in 108 HBV-
related HCCs' matched tumor and non-tomor tissue samples with different clinical outcomes and
26 normal liver specimens by real-time PCR. The expression stability of the 6 genes was compared
using the software programs geNorm and NormFinder. To show the impact of reference genes on
data analysis, we took PGK1 as a target gene normalized by each reference gene, and performed
one-way ANOVA and the equivalence test.
Results: With the geNorm and NormFinder software programs, analysis of TBP and HPRT1
showed the best stability in all tissue samples, while 18s and ACTB were less stable. When 18s or
ACTB was used for normalization, no significant difference of PGK1 expression (p > 0.05) was
found among HCC tissues with and without metastasis, and normal liver specimens; however,
dramatically differences (p < 0.001) were observed when either TBP or the combination of TBP
and HPRT1 were selected as reference genes.
Conclusion: TBP and HPRT1 are the most reliable reference genes for q-PCR normalization in
HBV-related HCC specimens. However, the well-used ACTB and 18S are not suitable, which
actually lead to the misinterpretation of the results in gene expression analysis.
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Background
With the application of quantitative real-time polymerase
chain reaction (qPCR) in the high throughput and accu-
rate expression profiling of selected genes, gene expres-
sion analysis is increasingly significant in many fields of
biological research [1-3]. Nowadays, housekeeping genes
(HKGs) are routinely-used as references in qPCR to nor-
malize experimental data, such as differences in RNA
quantity and quality, the overall transcriptional activity
and differences in the cDNA synthesis [4], because, theo-
retically, HKGs are supposed to exhibit consistent, non-
regulated, stable expression among different space-time
and different tissues, even intervention models [5,6].
However, cancer development is a very complex stepwise
process involving altered cell functions at many steps,
through changing almost all genes in gene expression
[7,8]. And many experimental evidences indicate that
even the so-called HKGs are involved in tumorigenesis,
including breast, prostate, colorectal, and bladder-cancer
[9-16]. Typical HKGs including glyceraldehydes 3-phos-
phate dehydrogenase (GAPDH), beta-actin (ACTB),
TATA-binding protein (TBP), 18S ribosomal RNA (18S)
and many more have often been adopted from the litera-
tures as reference genes without taking into account their
specific tissue dependent behavior or the special design of
the respective study [6,9-16]. Being de-regulated in vari-
ous samples actually, those so-called HKGs for qPCR nor-
malization on cancer research may lead to unreliable
results and consequently misinterpretation [13,15,17].
Therefore, it is crucial to find appropriate reference genes
for qPCR normalization on specific cases.
The major risk factor for the development of HCC is cir-
rhosis of the liver after chronic hepatitis virus infection.
Recently, the geographical variability in the incidence of
HCC has been attributed to the changing distribution and
the natural history of hepatitis B virus (HBV) and hepatitis
C virus (HCV) infection [18]. Therefore, HCV is the most
important risk factor for HCC in western European and
North American countries, while HBV is the major risk
factor in East Asia, a distinct HCC subtype with an increas-
ingly worldwide prevalence. However, evidence shows
that HKG expression profile of HBV is distinct from HCV
and relevant to hepatocarcinogenesis [19]. Recently, it
was reported that in HCV-induced HCC, the combination
of RPL41 and SFRS4 were the best to normalize qPCR data
in USA [20], and there was no significant different in
HKGs expression in the liver cancer tissues derived from
HBV-infected and non-infected patients [21].
Based on one of the tumorigenesis and metastasis theories
that genes favoring metastasis progression are initiated in
the primary tumors [22,23], it is becoming a routine strat-
egy to compare gene expression levels in tumor samples
with different prognostic outcomes: cancer with- and
without- metastasis [24-27], to find clinical prognosis
biomarkers. Up to date, initial evidence shows GAPDH
and ACTB are de-regulated in various TNM stages and
tumor invasiveness in HCC [21]. Therefore, it is necessary
to identify suitable reference genes relevant to HBV-
related HCC with different clinical outcomes, which there
is no previous systematic investigation yet.
This study focused on the commonly used HKGs as refer-
ence genes for q-PCR normalization in matched tumor
and non-tumor tissue samples with different outcomes
(with or without metastasis in 3 years following up) of
HBV-related HCC and normal liver specimens. To select
the commonly-used HKGs in HBV-related HCC, we
searched on PubMed using the MeSH terms "hepatocellu-
lar carcinoma", "gene expression", and "RT-PCR" com-
bined with the Boolean operator "AND" from January
2005 to March 2008 [15,28]. We evaluated 69 articles that
had used various reference genes, and found that beta-
actin (ACTB; 25 times; 36%), glyceraldehydes-3-phos-
phate dehydrogenase (GAPDH; 19 times; 28%), 18S-r
RNA (18S; 12 times; 17%), TATA box binding protein
(TBP; 5 times; 7%) and Hypoxanthine phosphoribosyl-
transferase I (HPRT1; 4 times; 6%) and ribosomal protein
L 13a (RPL13A; 4 times; 6%) were commonly used (Table
1). The six HKGs were selected, and their expression levels
in normal liver tissues, tumor tissues (with-metastasis or
without-metastasis HCC) and paired adjacent non-tumor
liver tissues were compared to identify suitable reference
genes for the purpose of normalization in HBV-related
HCC.
Methods
Patients and specimens
Surgical tissue specimens from Chinese patients with pri-
mary HBV-related HCC were collected with informed con-
sent and approved by the Institutional Review Board of
the Liver Cancer Institute and Zhongshan Hospital, Fudan
University (Shanghai, China). A total of 108 paired HCC
tissues samples and adjacent non-malignant liver tissues
were collected from the patients undergoing surgery at the
Liver Cancer Institute during the period October 2003 to
March 2005. The 108 paired samples were divided into
with-metastasis and without-metastasis two subgroups
based on their clinical prognostic features in 3 years fol-
lowing-up investigations. The clinicopathological charac-
teristics of patients were presented in Table 2. All samples
were histopathologically diagnosed as HCC according to
Edmondson's classification. Pathologic diagnosis was
independently done by two pathologists. An additional
26 normal liver specimens from patients with non-HCC
liver disease were previously described [22]. The samples
were sectioned immediately after surgical removal. Suita-BMC Cancer 2009, 9:49 http://www.biomedcentral.com/1471-2407/9/49
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ble tissue pieces were snap-frozen in liquid nitrogen and
stored at -80°C until further processing.
RNA isolation and characterization
The tissue specimen were ground in liquid nitrogen and
homogenized in Trizol (Invitrogen, Carlsbad, CA) using a
poltroon homogenizer. Total RNA was purified following
the RNeasy Mini protocol (Qiagen, Valencia, CA), includ-
ing a DNaseI digestion, to avoid contamination with
genomic DNA. The concentration of the isolated RNA and
the ratio of absorbance at 260 nm to 280 nm (A260/A280
ratio) were measured with NanoDrop ND-1000 spectro-
photometer (NanoDrop Technologies, Montchanin, DE,
USA). The accuracy of the measurements on the Nano-
Drop spectrophotometer was previously controlled by
comparative measurements using the conventional UV
spectrophotometer Ultrospec 3000 (Pharmacia). The
integrity of RNA was assessed with the RNA 6000 Nano
LabChip kit using the Agilent 2100 Bioanalyzer (Agilent
Technologies, Palo Alto, CA, USA). The electrophero-
grams and gel-like images were evaluated with the Agilent
2100 Expert software that generates the RNA integrity
number (RIN) to characterize RNA integrity. This number
describes a gradual scale of RNA integrity from 1 (RNA
completely degraded) to 10 (RNA without degradation),
taking into account not only the conventional ratio of 28S
to 18S ribosomal RNA (rRNA) but also other critical
regions of the entire RNA electropherogram. The thresh-
old inclusion values for the RNA samples were >1.90 for
the A260/A280 ratio and >7 for the RIN value.
First-strand cDNA synthesis
First-strand cDNA was synthesized using oligo dT and
SuperScript™ III reverse transcriptase according to the
manufacturer's instructions (Invitrogen, Carlsbad, CA,
USA). Before transcription, RNA was denatured for 5 min
at 65°C followed by cooling on ice. Finally, the Reverse
Transcriptase was inactivated by heating the reaction mix-
ture for 5 min at 93°C. All cDNAs was stored at -20°C
until RT-PCR analysis. They were diluted 1:50 and 4.5 μl
were used as template in a 10 μl qPCR reaction.
Real-time PCR
The ABI Prism 7900 HT Sequence Detection System
(Applied Biosystems, Foster City, CA, USA) was used for
real-time PCR instruments. Essential gene-specific data
are given in Table 1. The measurements on the ABI Prism
System were performed with primers and TaqMan MGB
probes as previously described [5]. The TaqMan probes
were 5'-labeled with the reporter fluorescent dye 6-car-
boxy-fluorescein (FAM) and carried the quencher dye 6-
carboxy-tetramethyl-rhodamine (TAMRA) labelled on a
thymidine base near the 3'terminus. The amplification
procedures were performed under the same reaction con-
ditions as previously described in detail [5]. Briefly, the
cycle conditions were set as follows: start with 2 min,
50°C step is required for optimal AmpErase® UNG activ-
ity, 10 min template denaturation at 95°C, 40 cycles of
denaturation at 95°C for 15 s, and combined primer
annealing/elongation at 60°C for 1 min.
Data analysis
Statistical analyses were performed with SPSS 15.0 for
Windows (SPSS Software, Chicago, IL, USA). P values
<0.05 were considered statistically significant. For stabil-
ity comparison of candidate reference genes, we applied
the software geNorm, version 3.4 [4], and NormFinder
[29]. The program geNorm is a Visual Basic application
tool for Microsoft Excel and is available on the Internet
upon request by the programmers. CT values were con-
verted into relative quantities for analysis with geNorm
[4]. The program selects from a panel of candidate refer-
ence genes the two most stable genes or a combination of
multiple stable genes for normalization. The NormFinder
is also freely available on the Internet http://www.mdl.dk.
It is a Microsoft Excel add-in and calculates the stability
values of the individual candidate reference genes for nor-
malization [29]. The stability value is based on the com-
Table 1: Six housekeeping genes evaluated in this study
Gene symbol Gene name Accession number Primer/probe*
18S rRNA 18S ribosomal RNA X03205 Hs99999901_s1
ACTB β- Actin NM_001101 Hs99999903_m1
GAPDH Glyceraldehyde-3-phosphate dehydrogenase NM_002046 Hs01922876_u1
HPRT1 Hypoxanthine phosphoribosyl-transferase I NM_000194 Hs99999909_m1
RPL13A Ribosomal protein, large,13A NM_012423 Hs03043887_gH
TBP TATA box binding protein NM_003194 Hs00427620_m1
*ABI Gene expression Assay IDBMC Cancer 2009, 9:49 http://www.biomedcentral.com/1471-2407/9/49
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Table 2: Clinic pathological characteristics of patients enrolled in this study
HCC without metastasis (N = 63) HCC with metastasis (N = 45) Normal (N = 26)
Clinical variable n % n % n %
Sex
Male 46 73.02% 39 86.67% 9 34.62%
Female 17 26.98% 6 13.33% 17 65.38%
Age (years)
≤ 50 33 52.38% 24 53.33% 16 61.54%
>50 30 47.62% 21 46.67% 10 38.46%
HBV
+ 63 100.00% 45 100.00% 26 100.00%
-
Liver cirrhosis
Yes 16 25.40% 7 15.56% 24 92.31%
No 47 74.60% 37 82.22% 2 7.69%
Unknown 1 2.22%
Child-Pugh staging
A 40 63.49% 36 80.00% N/A N/A
B 19 30.16% 9 20.00% N/A N/A
C 4 6.35% N/A N/A
Tumor size (cm)
≤ 3 20 31.75% 27 60.00% N/A N/A
3~5 27 42.85% 18 40.00% N/A N/A
>5 16 25.40% N/A N/A
Edmondson grade
I 3 4.76% 2 4.44% N/A N/A
II 50 79.37% 30 66.67% N/A N/A
III 8 12.70% 9 20.00% N/A N/A
Unknown 2 3.17% 4 8.89% N/A N/A
AFP (ng/ml)BMC Cancer 2009, 9:49 http://www.biomedcentral.com/1471-2407/9/49
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bined estimate of intra- and inter-group expression
variations of the genes studied. A low stability value indi-
cating a low combined intra- and inter-group variation
proves high expression stability. Using this approach, the
most stable single gene is calculated and an additional
combination of two genes is recommended because the
stability value of that combination is generally lower than
that of the single gene.
Results
Expression levels of the "housekeeping" genes inHBV-
related HCC
We observed the expression levels of the selected 6 house-
keeping genes in different kinds of tissues, including nor-
mal liver tissue, malignant and paired non-malignant
tissues from patients with HBV-related HCC. Their clin-
icopathological characteristics were shown in Table 2. The
6 housekeeping genes studied displayed a wide expression
≤ 20 27 42.86% 14 31.11% 25 96.15%
20~200 11 17.46% 13 28.89% 1 3.85%
>200 25 39.68% 18 40.00%
Abbreviation: N/A, not available
Table 2: Clinic pathological characteristics of patients enrolled in this study (Continued)
Expression level of candidate reference genes Figure 1
Expression level of candidate reference genes. We observed the six housekeeping genes in normal liver specimens(Nor-
mal), paired tumor and non-tumor liver specimens of HCCs with-metastasis (TM and PM), paired tumor and non-tumor liver 
specimens of HCCs without-metastasis (TNM and PNM). Values are given as real-time PCR cycle threshold numbers (Ct val-
ues). Boxes represent the lower and upper quartiles with medians. The arbitrary lines at Ct 18, 23 and 28 distinguish the 
groups of differently expressed housekeeping genes.BMC Cancer 2009, 9:49 http://www.biomedcentral.com/1471-2407/9/49
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range, with the Ct values from 14 to 33 (Fig. 1). All of
them showed an approximately normal distribution pat-
tern proved by the Kolomogorov-Simirnov One-sample
Test in all kinds of tissues tested. The expression levels
were divided into three arbitrary ranges. The highest
expression level with the lowest Ct value below 18 cycles
was found in 18S; and a relatively lower expression level
with the highest Ct value above 28 cycles was observed in
TBP gene. The expression levels of GAPDH, ACTB,
RPL13A and HPRT1 were higher than that of TBP with rel-
atively lower Ct values ranged from 18 to 28 cycles.
Expression stability of the housekeeping genes
In search of the most stable reference genes, the expres-
sion stabilities of the tested genes were validated with two
software programs, geNorm and NormFinder [4,29,30].
In the program geNorm, the expression stability of one
gene was validated by calculating M value based on the
average pairwise variation between all tested genes. The
lowest M value characterizes the genes with the best stabil-
ity. According to the published articles [4,30], stable
genes' M values were below the default limit of 1.5 in the
geNorm program. The average expression M values of the
6 candidate reference genes were demonstrated in Fig 2.
The expression stabilities of the tested genes were differ-
ent, with M values ranged from 0.1 to 0.3. The 18S was the
least stable housekeeping gene with the M value of 0.239;
TBP and HPRT1 were identified as the two most stable
genes, with the M values of 0.127 and 0.131, respectively.
In addition, we, for the first time, found the variance of
the M value of these reference genes in different kinds of
tissues (Fig. 2). Again, the M value of 18S was the most
fluctuant gene among the six investigated HKGs, while
TBP and HPRT1 were the most stable ones in all groups
except the malignant without-metastasis (TNM) and the
combination of the normal and TNM groups, in which
GAPDH ranked the top.
The NormFinder program was also used to calculate the
expression stabilities of the 6 reference genes, in which
higher expression stability is indicated by a lower stability
value as an estimate of the combined intra- and inter-
group variation of the individual gene [29]. TBP and
HPRT1 were still found to be the most stable genes, and
TBP was the best one with a stability value of 0.294 (Fig
3). The combination (calculated geometric average [6]) of
TBP and HPRT1 could improve the stability value to
0.291; however, there was not significant difference com-
pared the stability of the combination with that of TBP
alone (0.294).
Significance of suitable reference gene's normalization 
forqPCR
Phosphoglycerate kinase 1 (PGK1) plays an important
role in tumour angiogenesis as a disulphide reductase.
The secretion of PGK1 is regulated independently and
inversely of its production and is consistent with the cor-
relation between tumour hypoxia and angiogenesis
[31,32]. To demonstrate the significance of suitable refer-
ence genes for normalization in order to get correct profil-
ing data, we measured mRNA expression level of PGK1 in
10 normal liver tissues and 22 paired (tumor and non-
tumor) tissue samples from patients with HCC (11 with-
metastasis, 11 without-metastasis). The normalization of
PGK1 expression was performed using different strategies:
approaches with two reference genes (TBP and HPRT1)
calculated by NormFinder and geNorm, or single (18S,
RPL13A, ACTB, GAPDH, HPRT1, TBP) reference gene. The
effect of different normalization approaches on the
expression levels of PGK1 in different tissue samples were
shown in Fig. 4. In addition, the P-values of the normal-
ized PGK1 expression levels among the 5 sample groups
were calculated (Table 3). When 18S and ACTB were used
for normalization, no significant difference in the result-
ing relative gene expression levels of PGK1 (p > 0.05)
could be found between the tumor with metastasis group
(TM) and tumor without metastasis group (TNM) or nor-
mal liver tissues group (Normal). In contrast, when TBP,
or the combination of TBP and HPRT1 were used, dra-
matic differences were found among the three groups (p <
0.001).
Discussion
In this study, we focused on qPCR data normalization in
HBV-related HCC with different prognostic outcomes,
where no conclusive systematic study comparing the suit-
ability of different candidate reference genes has been
published to date. All the experimental data and the
results arising from the subsequent calculations were
based on the particular design of the study: (1) using nor-
mal liver tissues for control; (2) dividing the HCCs into
two groups, with-metastasis and without-metastasis
according to 3 years following up; (3) enrolling modest
samples to follow consequently statistical tests; (4) strictly
controlling the isolated RNA; (5) using two different soft-
ware programs to assess the candidate genes regarding
their suitability as references; and (6) taking a target gene
as an example to show the significance of suitable refer-
ence genes on normalization. All these characteristics of
experimental design were significantly necessary for the
reliability of data and the conclusions derived from them.
In the present study, the best-performing or combinations
of reference genes were determined using the software
programs geNorm as well as NormFinder [4,30]. Identify-
ing suitable housekeeping genes is a both time consuming
and expensive process, and has resulted in development
of various programs and methods. The geNorm and
NormFinder programs have been used in many studies to
find suitable reference genes from a set of candidate genesBMC Cancer 2009, 9:49 http://www.biomedcentral.com/1471-2407/9/49
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[17,29,33]. In this study, 6 housekeeping genes, ACTB,
GAPDH, 18S, HPRT1, RPL13A and TBP, were selected to
evaluate their suitability as reference genes for relative
quantification of target genes expression in HBV-related
HCC. Both programs equally identified TBP and HPRT1
as the most stable combined reference genes. And more,
TBP alone was shown to be stable enough as reference
gene in this study. Recently, TBP is also recommended in
the study of human renal cell carcinoma (RCC), although
it is not as well-used as the other five references [28]. In
our study, the use of TBP alone as control gene show suf-
ficient (Fig. 3), which might because that our optimal
study conditions resulting in high-quality RNA samples
made only one reference gene necessary. HPRT1 was rec-
ommended as a universal, single reference gene for differ-
ential expression studies in cancer research [34]. However,
based on the results of this study, it seemed to be not as
stable as TBP, at least in HBV-related HCC. For the gene
expression study in HCC tissues, appropriate reference
genes in a range similar to the target genes are recom-
mended for normalization.
Selection of the most suitable reference genes using geNorm analysis Figure 2
Selection of the most suitable reference genes using geNorm analysis. We performed geNorm analysis in variable 
combinations of each group according to different specific interest in cancer studies. The value of M was calculated for each 
gene, clustered in one group. The lowest M value characterizes genes with the most stable expression. The X-axis from left to 
right indicates the ranking of the genes according to their expression stability.
 BMC Cancer 2009, 9:49 http://www.biomedcentral.com/1471-2407/9/49
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In this study, our findings indicate that the use of inappro-
priate genes for normalization can lead to under- or over-
estimations of the relative gene expression levels or to
misinterpretations of the results. The normalization for
target genes expression was used as an example to illus-
trate the essentiality of a suitable reference gene selected
from a panel of candidate reference genes. We used PGK1,
which plays a significance role in HCC tumourigenesis
[31,32], as a target gene. The results showed that unsuita-
ble reference genes led serious gene quantification error
interpretations. We recommend the use of TBP and
HPRT1 for normalizing expression results using the geo-
metric averaging of the two reference genes [4]. Although
the advantage of using both reference genes for normaliz-
ing is not clearly evident than using the most stable gene
TBP alone in our study, a more accurate normalization
was found by other investigators when more than one ref-
erence gene was used [4,33,35].
In addition, all HCC samples in this study were obtained
from HBV-positive Chinese patients. It remains to be
determined whether this result also can be applied to
other populations. Recently, it was reported that in HCV-
induced HCC the combination of RPL41 and SFRS4 were
best to normalize qPCR data in USA [20]. Studies are
under way to further explain why those housekeeping
genes are deregulated in different conditions, and more
molecular mechanism waits to find out.
Suitable reference genes for normalization and the best combination calculated by NormFinder program Figure 3
Suitable reference genes for normalization and the best combination calculated by NormFinder program. High 
expression stability is indicated by a low stability value as an estimate of the intra- and inter-group variation of the individual 
gene. The X-axis from left to right indicates the ranking of the genes according to their stability values.
Table 3: Alterations (P values) in gene expression level of PGK1 
by different reference genes' normalizations
Reference gene Totala Normal/TMa Normal/TNMa TM/TNMb
TBP and HPRT1 0.005 0.002 0.338 0.027
TBP 0.030 0.017 0.868 0.024
HPRT1 0.002 0.001 0.263 0.016
RPL13A 0.004 0.004 0.748 0.008
GAPDH 0.054 0.024 0.806 0.043
18S 0.343 0.717 0.312 0.504
ACTB 0.385 0.792 0.995 0.782
a: One-Way ANOVA
b: Paired-samples t testBMC Cancer 2009, 9:49 http://www.biomedcentral.com/1471-2407/9/49
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Conclusion
In conclusion, comparing gene expression levels in mod-
erate specimens, including normal liver tissues, paired
tumor and non-tumor tissues of patients with HCC
(including different status of metastasis), our research
revealed two appropriate genes TBP and HPRT1 were reli-
able for normalization in the study of HBV-related HCC.
In addition, the effects of differentially expressed genes in
qPCR normalization were presented. Some of the "house-
keeping genes", such as 18S and ACTB, were found lead to
misinterpretations on experimental data because of their
unstable gene expressions in those tissues mentioned
above.
Abbreviations
HBV: Hepatitis B virus; HCC: Hepatocellular carcinoma;
qPCR: Quantitative polymerase chain reaction; HKGs:
Housekeeping genes; HCV: Hepatitis C virus.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
LYF carried out the study, and drafted the manuscript.
HLJ, QHY, NR, and HJZ participated in the design of this
study. JCW assisted in the statistical analysis. QZD and YZ
participated in correcting patient sample's following-up
investigation data. LXQ supervised this study, and
involved in revising it critically for important intellectual
Effect of different normalization approaches on the expression analysis of PGK1 Figure 4
Effect of different normalization approaches on the expression analysis of PGK1. RT-PCR measurements of PGK1 
and the corresponding reference genes were performed in 10 normal liver specimens (Normal), 11 pairs malignant (TM) and 
non-malignant (PM) with metastasis, 11 pairs malignant (TNM) and non-malignant (PNM) without metastasis liver samples. The 
Y-axis indicates the mean fold changes.
 BMC Cancer 2009, 9:49 http://www.biomedcentral.com/1471-2407/9/49
Page 10 of 11
(page number not for citation purposes)
content. All authors read and approved the final manu-
script.
Acknowledgements
We thank Dr. Ran Yan for assistance with the experimental design; Mr. 
Cao-Ming Huang for invaluable discussions and suggestions; Mrs. Xiao-Mei 
Yang for filing a large quantity of clinic patients' data and following up inves-
tigations; and Dr. Hui Xiong for his statistic assistance. This work was sup-
ported by research grants from China National Natural Science Foundation 
for Distinguished Young Scholars (30325041), the China National "863" 
Program (2006AA02Z473), Shanghai Science and Technology Developing 
Program (Grant No. 03DZ14024), Foundation for Outstanding Scholars in 
New Era, and the Key Project from the Ministry of Education of China.
References
1. Heid CA, Stevens J, Livak KJ, Williams PM: Real time quantitative
PCR.  Genome Res 1996, 6:986-994.
2. Bustin SA: Absolute quantification of mRNA using real-time
reverse transcription polymerase chain reaction assays.  J Mol
Endocrinol 2000, 25:169-193.
3. Rasmussen R: Quantification on the LightCycler.  In Rapid Cycle
Real-time PCR. Methods and Applications Edited by: Meuer S, Wittwer
C, Nakagawara K. Heidelberg: Springer Press; 2001:21-34. 
4. Thellin O, Zorzi W, Lakaye B, De BB, Coumans B, Hennen G, Grisar
T, Lgout A, Heinen E: Housekeeping genes as internal stand-
ards: use and limits.  J Biotechnol 1999, 75:291-295.
5. Radonic A, Thulke S, Mackay IM, Landt O, Siegert W, Nitsche A:
Guideline to reference gene selection for quantitative real-
time PCR.  Biochem Biophys Res Commun 2004, 313:856-862.
6. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De
Paepe A, Speleman F: Accurate normalization of real-time
quantitative RT-PCR data by geometric averaging of multi-
ple internal control genes.  Genome Biol 2002,
3(7):research0034.1-research0034.11.
7. Brumy AM, Richardson HE: Using Drosophila melanogaster to
map human cancer pathways.  Nat Rev Cancer 2005,
5(8):626-639.
8. Kopper L, Timar J: Genomics of prostate cancer: is there any-
thing to "translate"?  Pathol Oncol Res 2005, 11(4):197-203.
9. Lyng M, Laenkholm A-V, Pallisgaard N, Ditzel H: Identification of
genes for normalization of real-time RT-PCR data in breast
carcinomas.  BMC Cancer 2008, 8(1):20.
10. Hsiao LL, Dangond F, Yoshida T, Hong R, Jensen RV, Misra J, Dillon
W, Lee KF, Clark KE, Haverty P, et al.: A compendium of gene
expression in normal human tissues.  Physiol Genomics 2001,
7(2):97-104.
11. Butte AJ, Dzau VJ, Glueck SB: Further defining housekeeping, or
"maintenance" genes focus on "A compendium of gene
expression in normal human tissues".  Physiol Genomics 2001,
7(2):95-96.
12. De Kok JB, Roelofs RW, Giesendorf BA, Pennings JL, Waas ET, Feuth
T, Swinkels DW, Span PN: Normalization of gene expression
measurements in tumour tissues: comparison of 13 endog-
enous control genes.  Lab Invest 2005, 85(1):154-159.
13. Schmittgen TD, Zakrajsek BA: Effect of experimental treatment
on housekeeping gene expression: validation by real-time,
quantitative RT-PCR.  J Biochem Biophys Methods 2000, 46:69-81.
14. Goidin D, Mamessier A, Staquet MJ, Schmitt D, Berthier VO: Ribos-
omal 18S RNA prevails over glyceraldehydes-3-phosphat
dehydrogenate and beta-actin genes as internal standard for
quantitative comparison of mRNA levels in invasive and non-
invasive human melanoma cell subpopulations.  Anal Biochem
2001, 295:17-21.
15. Ohl F, Jung M, Xu C, Stephan C, Rabien A, Burkhardt M, Nitsche A,
Kristiansen G, Loening SA, Radonic A, et al.: Gene expression stud-
ies in prostate cancer tissue: which reference gene should be
selected for normalization?  J Mol Med 2005, 83(12):1014-1024.
16. Khimani AH, Mhashilkar AM, Mikulskis A, O'Malley M, Liao J, Golenko
EE, Mayer P, Chada S, Killian JB, Lott ST: Housekeeping genes in
cancer: normalization of array data.  Biotechniques 2005,
38(5):739-745.
17. Dheda K, Huggett JF, Chang JS, Kim LU, Bustin SA, Johnson MA, Rook
GA, Zumla A: The implications of using an inappropriate ref-
erence gene for real-time reverse transcription PCR data
normalization.  Anal Biochem 2005, 344:141-143.
18. Liu CJ, Kao JH: Hepatitis B virus-related hepatocellular carci-
noma: epidemiology and pathogenic role of viral factors.  J
Chin Med Assoc 2007, 70:141-145.
19. Pang R, Tse E, Poon RT: Molecular pathways in hepatocellular
carcinoma.  Cancer Lett 2006, 240:157-169.
20. Waxman S, Wurmbach E: De-regulation of common house-
keeping genes in hepatocellular carcinoma.  BMC Genomics
2007, 8:243-251.
21. Gao Q, Wang XY, Fan J, Qiu SJ, Zhou J, Shi YH, Xiao YS, Xu Y, Huang
XW, Sun J: Selection of reference genes for real-time PCR in
human hepatocellular carcinoma tissues.  J Cancer Res Clin Oncol
2008, 134:979-986.
22. Ye QH, Qin LX, Forgues M, He P, Kim JW, Peng AC, Simon R, et al.:
Predicting hepatitis B virus-positive metastatic hepatocellu-
lar carcinomas using gene expression profiling and super-
vised machine learning.  Nat Med 2003, 9:416-423.
23. Budhu A, Forgues M, Ye QH, Jia HL, He P, Zanetti KA, Kammula US,
Chen YD, Qin LX, Tang ZY, Wang XW: Prediction of venous
metastases, recurrence, and prognosis in hepatocellular car-
cinoma based on a unique immune response signature of the
liver microenvironment.  Cancer Cell 2006, 10:99-111.
24. Qin LX, Tang ZY, Sham JS, Ma ZC, Ye SL, Zhou XD, Wu ZQ, Trent
JM, Guan XY: The association of chromosome 8p deletion and
tumor metastasis in human hepatocellular carcinoma.  Can-
cer Res 1999, 59:5662-5665.
25. Khan J, Wei JS, Ringnér M, Saal LH, Ladanyi M, Westermann F,
Berthold F, Schwab M, Antonescu CR, Peterson C, Meltzer PS: Clas-
sification and diagnostic prediction of cancers using gene
expression profiling and artificial neural networks.  Nat Med
2001, 7:673-679.
26. Budhu A, Forgues M, Ye QH, Jia HL, He P, Zanetti KA, Kammula US,
Chen Y, Qin LX, Tang ZY, Wang XW: Prediction of venous
metastases, recurrence, and prognosis in hepatocellular car-
cinoma based on a unique immune response signature of the
liver microenvironment.  Cancer Cell 2006, 10:99-111.
27. Budhu A, Jia HL, Forgues M, Liu CG, Goldstein D, Lam A, Zanetti KA,
Ye QH, Qin LX, Croce CM, Tang ZY, Wang XW: Identification of
metastasis-related microRNAs in hepatocellular carcinoma.
Hepatology 2008, 47:897-907.
28. Jung M, Ramankulov A, Roigas J, Johannsen M, Ringsdorf M, Kris-
tiansen G, Jung K: In search of suitable reference genes for gene
expression studies of human renal cell carcinoma by real-
time PCR.  BMC Mol Biol 2007, 8:47-59.
29. Andersen CL, Jensen JL, Orntoft TF: Normalization of real-time
quantitative reverse transcription-PCR data: a model-based
variance estimation approach to identify genes suited fro
normalization, applied to bladder and colon cancer data
sets.  Cancer Res 2004, 64:5245-5250.
30. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De
Paepe A, Speleman F: GeNorm software manual, update 6 Sep
2004.   [http://medgen.ugent.be/~jvdesomp/genorm].
31. Lay AJ, Jiang XM, Kisker O, Flynn E, Underwood A, Condron R, Hogg
PJ: Phosphoglycerate kinase acts in tumor angiogenesis as a
disulphide reductase.  Nature 2000, 408:869-873.
32. Hwang TL, Liang Y, Chien KY, Yu JS: Overexpression and ele-
vated serum levels of phosphoglycerate kinase 1 in pancre-
atic ductal adenocarcinoma.  Proteomics 2006, 6:2259-2272.
33. Tricarico C, Pinzani P, Bianchi S, Paglierani M, Distante V, Pazzagli M,
Bustin SA, Orlando C: Quantitative realtime reverse transcrip-
tion polymerase chain reaction: normalization to rRNA or
single housekeeping genes is inappropriate for human tissue
biopsies.  Anal Biochem 2002, 309:293-300.
34. Szabo A, Perou CM, Karaca M, Perreard L, Quackenbush JF, Bernard
PS:  Statistical modeling for selecting housekeeper genes.
Genome Biol 2004, 5:R59-68.
35. Schmid H, Cohen CD, Henger A, Irrgang S, Schlöndorff D, Kretzler
M: Validation of endogenous controls for gene expression
analysis in microdissected human renal biopsies.  Kidney Int
2003, 64:356-360.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Cancer 2009, 9:49 http://www.biomedcentral.com/1471-2407/9/49
Page 11 of 11
(page number not for citation purposes)
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2407/9/49/prepub